Physician profile
James Conner Ryan
NPI 1386098150
$3,873.62
in general payments reported to CMS, 2019-2025
16 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $258 · 2023: $1,725 · 2024: $337 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230 · Travel and Lodging: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.96 |
| Travel and Lodging | $1,186.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,899.30 | 2022-2025 | Salvation, Mako, Iconix |
| Medinc of Texas | $1,200.00 | 2021 | |
| Omnilife Science, INC | $142.70 | 2024 | Apollo Hip V (Fka) Omnihip |
| Bioventus LLC | $131.32 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Encore Medical, LP | $113.50 | 2022 | |
| Depuy Synthes Sales INC. | $86.98 | 2024-2025 | Tfn-Advance, Na |
| Ferring Pharmaceuticals INC. | $82.20 | 2022-2023 | Euflexxa |
| Smith+Nephew, INC. | $52.05 | 2025 | Pico 14, Stravix |
| Davol INC. | $30.78 | 2025 | Surgiphor |
| Advanced Oxygen Therapy INC. | $27.36 | 2025 | Topical Oxygen Chamber For Extremities |
| Orthofix Medical, INC. | $22.22 | 2023 | Physio-Stim |
| Kerecis Limited | $20.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Avanos Medical | $18.66 | 2023 | Trivisc Sodium Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $16.59 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $16.35 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $13.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.